SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

NCT07575412 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
MDS
Transplantation, Stem Cell
Conditioning Therapy
SHR2554
Azacytidine

Interventions

DRUG: SHR2554/AZA + Overlapped mBUCY
DRUG: mBUCY conditioning Regimen Group

Sponsor

The First Affiliated Hospital of Soochow University